Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

How to Run Ipamorelin Cycle: Dosage Protocol Comparison

Conservative Start 600mcg (200mcg × 3) 3× daily (morning, afternoon, pre-bed) 8 weeks First-time peptide research, tolerance assessment Appropriate for initial receptor response evaluation; may require escalation after week 2–3 Standard Research 900mcg (300mcg

This comparison does not assign a generated winner or score.

  • Conservative Start
  • 600mcg (200mcg × 3)
  • 3× daily (morning, afternoon, pre-bed)
  • 8 weeks
  • First-time peptide research, tolerance assessment
  • Appropriate for initial receptor response evaluation; may require escalation after week 2–3
  • Standard Research
  • 900mcg (300mcg × 3)
  • 10–12 weeks
  • Muscle recovery studies, metabolic research
  • Gold standard for most research applications; maximises GH pulse without receptor saturation
  • Twice-Daily Moderate
  • 600mcg (300mcg × 2)
  • 2× daily (morning, pre-bed)
  • 12 weeks
  • Compliance-limited protocols, longevity research
  • Effective but suboptimal. Misses mid-day GH pulse; suitable when 3× daily dosing isn't feasible
  • Post-Workout Focused
  • 600–900mcg
  • 2–3× daily (post-workout + standard times)
  • 8–10 weeks
  • Athletic recovery research, injury healing studies
  • Leverages exercise-induced insulin suppression; timing critical within 15 min post-training
  • Synergistic Stack
  • 600mcg ipamorelin + 100mcg CJC-1295
  • 3× daily (ipamorelin) + 1× weekly (CJC-1295)
  • Advanced research requiring maximal GH/IGF-1 elevation
  • Produces 3–5× greater IGF-1 response than ipamorelin alone; requires precise dosing and monitoring
More references

Related material

Comparison

Protocol Comparison Analysis

Research comparing different peptide protocols has provided valuable insights into the relative effectiveness and safety profiles of various approaches. The cjc1295 ipamorelin cyc…

View details →